Companies seek to capitalize on hot Crispr gene tech, though patent dispute is unresolved http://on.wsj.com/2dcO2ix 
1 reply
27 retweets
30 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.